ChromaDex Corp has a consensus price target of $5.35 based on the ratings of 5 analysts. The high is $7 issued by Roth Capital on March 8, 2022. The low is $2.4 issued by B. Riley Securities on August 11, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Roth MKM, and HC Wainwright & Co. on July 15, 2024, June 12, 2024, and May 9, 2024, respectively. With an average price target of $6 between HC Wainwright & Co., Roth MKM, and HC Wainwright & Co., there's an implied 95.44% upside for ChromaDex Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/15/2024 | Buy Now | 95.44% | HC Wainwright & Co. | Raghuram Selvaraju | $6 → $6 | Reiterates | Buy → Buy | Get Alert |
06/12/2024 | Buy Now | 95.44% | Roth MKM | Sean McGowan | $6 → $6 | Maintains | Buy | Get Alert |
05/09/2024 | Buy Now | 95.44% | HC Wainwright & Co. | Raghuram Selvaraju | → $6 | Reiterates | Buy → Buy | Get Alert |
04/09/2024 | Buy Now | 95.44% | Roth MKM | Sean McGowan | $4.25 → $6 | Maintains | Buy | Get Alert |
03/11/2024 | Buy Now | 95.44% | HC Wainwright & Co. | Raghuram Selvaraju | $5 → $6 | Maintains | Buy | Get Alert |
08/10/2023 | Buy Now | 62.87% | HC Wainwright & Co. | Raghuram Selvaraju | → $5 | Reiterates | Buy → Buy | Get Alert |
06/05/2023 | Buy Now | 62.87% | HC Wainwright & Co. | Raghuram Selvaraju | → $5 | Reiterates | Buy → Buy | Get Alert |
03/13/2023 | Buy Now | 62.87% | HC Wainwright & Co. | Raghuram Selvaraju | $5.5 → $5 | Maintains | Buy | Get Alert |
02/01/2023 | Buy Now | 79.15% | HC Wainwright & Co. | Raghuram Selvaraju | → $5.5 | Reiterates | → Buy | Get Alert |
08/29/2022 | Buy Now | 79.15% | HC Wainwright & Co. | Raghuram Selvaraju | $7 → $5.5 | Maintains | Buy | Get Alert |
08/16/2022 | Buy Now | — | Oppenheimer | Brian Nagel | — | Downgrade | Outperform → Perform | Get Alert |
08/11/2022 | Buy Now | -21.82% | B. Riley Securities | Jeff Van Sinderen | $6 → $2.4 | Downgrade | Buy → Neutral | Get Alert |
06/07/2022 | Buy Now | 128.01% | HC Wainwright & Co. | Raghuram Selvaraju | $8 → $7 | Maintains | Buy | Get Alert |
05/13/2022 | Buy Now | 95.44% | B. Riley Securities | Jeff Van Sinderen | $8 → $6 | Maintains | Buy | Get Alert |
04/18/2022 | Buy Now | 160.59% | HC Wainwright & Co. | Raghuram Selvaraju | $12 → $8 | Maintains | Buy | Get Alert |
03/10/2022 | Buy Now | 160.59% | B. Riley Securities | Jeff Van Sinderen | $16 → $8 | Maintains | Buy | Get Alert |
03/08/2022 | Buy Now | 128.01% | Roth Capital | Sean McGowan | → $7 | Initiates | → Buy | Get Alert |
08/04/2021 | Buy Now | 290.88% | HC Wainwright & Co. | Raghuram Selvaraju | — | Maintains | Buy | Get Alert |
The latest price target for ChromaDex (NASDAQ:CDXC) was reported by HC Wainwright & Co. on July 15, 2024. The analyst firm set a price target for $6.00 expecting CDXC to rise to within 12 months (a possible 95.44% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for ChromaDex (NASDAQ:CDXC) was provided by HC Wainwright & Co., and ChromaDex reiterated their buy rating.
There is no last upgrade for ChromaDex
The last downgrade for ChromaDex Corp happened on August 16, 2022 when Oppenheimer changed their price target from N/A to N/A for ChromaDex Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ChromaDex, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ChromaDex was filed on July 15, 2024 so you should expect the next rating to be made available sometime around July 15, 2025.
While ratings are subjective and will change, the latest ChromaDex (CDXC) rating was a reiterated with a price target of $6.00 to $6.00. The current price ChromaDex (CDXC) is trading at is $3.07, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.